Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of 611 in chronic rhinosinusitis with nasal polyps
CTR20243786Phase 3Completed
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Nov 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SSGJ-611 in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by 3S Guojian Pharmaceutical. Started Nov 2024; status: completed.
02
Drugs
SSGJ-611
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20243786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243786.